Follow-up schedule based on evidence of melanoma recurrences in 200 patients, a monoinstitutional experience

Background: Optimal follow up modalities for patients with melanoma after primary surgery is not unanimously defined by major scientific societies (AIOM, ASCO, NCCN). We have evaluated when and how recurrence was detected among 200 pts with melanoma followed in our institution. Material and methods: We have retrospectively reviewed the clinical records of 200 consecutive pts, diagnosed with melanoma stage IA to III C in 2009-2010 and followed...